This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Aug;13(4):115.

doi: 10.1136/ebm.13.4.115.

Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn's disease

John K Marshall¹

Affiliations

PMID: 18667674
DOI: 10.1136/ebm.13.4.115

Comment

Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn's disease

John K Marshall. Evid Based Med. 2008 Aug.

. 2008 Aug;13(4):115.

doi: 10.1136/ebm.13.4.115.

Author

John K Marshall¹

Affiliation

¹ McMaster University, Hamilton, Ontario, Canada.

PMID: 18667674
DOI: 10.1136/ebm.13.4.115

No abstract available

PubMed Disclaimer

Comment on

Review article: the evidence base for interventions used to maintain remission in Crohn's disease.
Akobeng AK. Akobeng AK. Aliment Pharmacol Ther. 2008 Jan 1;27(1):11-8. doi: 10.1111/j.1365-2036.2007.03536.x. Epub 2007 Oct 5. Aliment Pharmacol Ther. 2008. PMID: 17919275 Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.